Lise Lotte Gluud

University of Copenhagen — Denmark

Medicine · Health Sciences

73h-index27.1kcitations423works3.92yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Liver Disease Diagnosis and Treatment(240), Liver Disease and Transplantation(146), Organ Transplantation Techniques and Outcomes(48), Diet, Metabolism, and Disease(33), Diabetes Treatment and Management(32)

Publications419 total

Distinct and complementary metabolic effects of GLP-1 and glucagon receptor agonism in diet-induced obese mice
Peptides·2025Open Access
Effects of zibotentan and dapagliflozin combined in patients with compensated cirrhosis: A randomized placebo‐controlled exploratory study
British Journal of Clinical Pharmacology·2025
Role of bioimpedance spectroscopy analysis to assess hydration status in the early phase of acute pancreatitis
Pancreatology·2025Open Access
The burden of extrahepatic organ failures in European patients with cirrhosis
Hepatology Communications·2025Open Access
Metabolic dysfunction‐associated steatotic liver disease, cardiometabolic risk factors, and cardiac manifestations in psoriasis: A cross‐sectional study of 255 patients
Journal of Internal Medicine·2025
Pre-emptive TIPS should be considered in high-risk patients with both acute variceal bleeding and severe alcohol-related hepatitis
JHEP Reports·2025Open Access
Glucagon increases plasma levels of cyclic AMP responses in mice and humans, and this may be independent of MASLD
American Journal of Physiology-Endocrinology and Metabolism·2025Open Access
Decoding Fibrosis: Transcriptomic and Clinical Insights via AI-Derived Collagen Deposition Phenotypes in MASLD
2025Open Access
Cardiovascular implications of MASLD: overview of the evidence
Scandinavian Journal of Gastroenterology·2025· 2 cited
Modulation of metabolic, inflammatory and fibrotic pathways by semaglutide in metabolic dysfunction-associated steatohepatitis
Nature Medicine·2025· 31 citedOpen Access
Diagnostics of Autoimmune Hepatitis Enabled by Non‐Invasive Clinical Proteomics
Alimentary Pharmacology & Therapeutics·2025· 1 citedOpen Access
Alterations in one-carbon metabolism in metabolic dysfunction associated steatotic liver disease may be modified by semaglutide
Annals of Hepatology·2025Open Access
Prognostic Value of the <scp>TLM3</scp> Biomarker Panel for Early Fibrosis Development in <scp>MASLD</scp> Within the General Population
Liver International·2025· 1 citedOpen Access
Genome-wide meta-analysis identifies nine loci associated with higher risk of hepatocellular carcinoma development
JHEP Reports·2025· 5 citedOpen Access
The hepatic transcriptome is differentially regulated by a standardized meal in healthy individuals compared to patients with fatty liver disease
PLoS ONE·2025· 1 citedOpen Access
P198 Resolution of metabolic dysfunction-associated steatohepatitis with semaglutide via modulation of multiple pathogenic pathways: insights from human and animal omics studies
2025
Mechanisms of drug induced liver injury
Cellular and Molecular Life Sciences·2025· 19 citedOpen Access
Disease classification, diagnostic challenges, and evolving clinical trial design in MASLD
Journal of Clinical Investigation·2025· 9 citedOpen Access
FRI-226 The burden of extrahepatic organ failures in european patients with cirrhosis
Journal of Hepatology·2025
FRI-139 Lipid metabolites in acute and chronic liver damage: Do N-acyl taurines protect the liver?
Journal of Hepatology·2025
page 1 of 21Next →

Frequent Co-authors

Christian Gluud(18), Aleksander Krag(9), Dimitrinka Nikolova(8), Bodil Als‐Nielsen(8), Filip K. Knop(8), Goran Bjelaković(7), Tina Vilsbøll(7), Rosa G Simonetti(6), Agustı́n Albillos(5), José Luís Calleja(4), Mikkel Christensen(4), Jørn Wetterslev(4), Jens J. Holst(4), Peter Jüni(3), Jonathan A C Sterne(3), Elisabetta Bugianesi(3), Kate Whitfield(3), Hendrik Vilstrup(3), Mikkel Parsberg Werge(3), Virginia Hernández–Gea(3)